Sino Medical Sciences Technology In Net Asset Quality Index
Sino Medical Sciences Technology In net asset quality index. Sino Medical Sciences Technology In (688108) has a Net Asset Quality Index of 79.0% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.36 Billion minus total liabilities of CN¥285.74 Million yields net assets of CN¥1.07 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Sino Medical Sciences Technology In (688108) net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Sino Medical Sciences Technology In (2016–2025)
Net asset quality index of Sino Medical Sciences Technology In from 2016 to 2025. This chart shows how Sino Medical Sciences Technology In's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the index stands at 79.0%, representing net assets of CN¥1.07 Billion against total assets of CN¥1.36 Billion CNY. Check 688108 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Sino Medical Sciences Technology In Net Asset Quality Index by Year (2016–2025)
Sino Medical Sciences Technology In net asset quality index by year from 2016 to 2025. The table below presents the year-by-year Net Asset Quality Index for Sino Medical Sciences Technology In from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Sino Medical Sciences Technology In.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 169.0% | CN¥2.28 Billion | CN¥1.35 Billion | CN¥-931.81 Million | ▲ +100.0 pp |
| 2024 | 69.1% | CN¥898.34 Million | CN¥1.30 Billion | CN¥402.22 Million | ▼ -3.6 pp |
| 2023 | 72.7% | CN¥861.65 Million | CN¥1.19 Billion | CN¥324.17 Million | ▼ -10.5 pp |
| 2022 | 83.1% | CN¥887.48 Million | CN¥1.07 Billion | CN¥180.13 Million | ▼ -2.6 pp |
| 2021 | 85.7% | CN¥945.16 Million | CN¥1.10 Billion | CN¥157.92 Million | ▼ -2.8 pp |
| 2020 | 88.5% | CN¥1.08 Billion | CN¥1.22 Billion | CN¥139.63 Million | ▼ -2.6 pp |
| 2019 | 91.1% | CN¥1.10 Billion | CN¥1.21 Billion | CN¥107.11 Million | ▲ +4.1 pp |
| 2018 | 87.0% | CN¥701.28 Million | CN¥806.10 Million | CN¥104.83 Million | ▲ +1.6 pp |
| 2017 | 85.4% | CN¥606.70 Million | CN¥710.33 Million | CN¥103.62 Million | ▲ +13.2 pp |
| 2016 | 72.2% | CN¥202.75 Million | CN¥280.81 Million | CN¥78.06 Million | — |